...
机译:达芦那韦/利托那韦加利匹韦林每天一次与抑制病毒血症患者三联治疗的 96 周结果:病毒学成功和非 HIV 相关发病率评估
Univ Milan;
CNR;
Policlin San Matteo FdnUniv BariASST Valle OlonaUniv TurinASST Fatebenefratelli SaccoCtr Riferimento HIV & Malattie Sessualmente TrasmOsped Oncol San Giuseppe MoscatiUniv Campania Luigi VanvitelliSan Gerardo Hosp;
HIV-1; Darunavir; Rilpivirine; Dual therapy; Immunovirological success; Safety; METABOLIC SYNDROME; OPEN-LABEL; MAINTENANCE; LAMIVUDINE; TENOFOVIR;